ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 699,62
0,49%
Dow Jones
39 112,16
-0,76%
DAX
18 346,04
1,01%
Brent Oil
84,515
0,39%
Bitcoin
61 684,94
-0,20%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Novus Therapeutics Inc (NVUS)

  7. Novus Therapeutics Inc (NVUS) Actualités

NVUS

Novus Therapeutics (NVUS)

Novus Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NVUS
DateHeureSourceTitreSymboleSociété
22/06/202312h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVUSNovus Therapeutics Inc
08/06/202322h05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:NVUSNovus Therapeutics Inc
05/06/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NVUSNovus Therapeutics Inc
22/05/202319h27Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:NVUSNovus Therapeutics Inc
18/05/202323h16Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NVUSNovus Therapeutics Inc
11/05/202323h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVUSNovus Therapeutics Inc
03/05/202300h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
01/05/202322h53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVUSNovus Therapeutics Inc
01/05/202322h49Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVUSNovus Therapeutics Inc
24/03/202222h05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NVUSNovus Therapeutics Inc
14/02/202221h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVUSNovus Therapeutics Inc
21/05/202123h04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:NVUSNovus Therapeutics Inc
20/04/202113h00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVUSNovus Therapeutics Inc
12/04/202112h04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NVUSNovus Therapeutics Inc
16/02/202122h43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVUSNovus Therapeutics Inc
05/01/202122h39Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NVUSNovus Therapeutics Inc
22/12/202022h50Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:NVUSNovus Therapeutics Inc
13/11/202023h05Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:NVUSNovus Therapeutics Inc
02/11/202014h00Business WireNovus Therapeutics Announces First Patient Enrolled in Phase 2a Clinical Trial of Anti-CD40L Antibody AT-1501 in Amyotrophic ...NASDAQ:NVUSNovus Therapeutics Inc
23/10/202023h17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:NVUSNovus Therapeutics Inc
02/10/202017h00Business WireNovus Therapeutics Announces One-for-Eighteen Reverse Stock SplitNASDAQ:NVUSNovus Therapeutics Inc
15/09/202022h56Business WireNovus Therapeutics to Present at H.C. Wainwright and Cantor Global Investment ConferencesNASDAQ:NVUSNovus Therapeutics Inc
14/09/202022h31Business WireNovus Therapeutics Announces Acquisition of Anelixis TherapeuticsNASDAQ:NVUSNovus Therapeutics Inc
25/03/202021h07Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:NVUSNovus Therapeutics Inc
20/02/202012h12Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:NVUSNovus Therapeutics Inc
22/07/201912h00GlobeNewswire Inc.Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB MarketNASDAQ:NVUSNovus Therapeutics Inc
01/05/201912h45Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NVUSNovus Therapeutics Inc
30/04/201922h11Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NVUSNovus Therapeutics Inc
07/09/201815h02Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:NVUSNovus Therapeutics Inc
04/09/201822h40Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:NVUSNovus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NVUS

Dernières Valeurs Consultées

EU
CAP
Capgemini
EU
ORA
Orange
EU
BNP
BNP Paribas
EU
PX1
CAC 40
NYSE
MRK
Merck
NYSE
MCD
McDonalds
SPI
SP500
S&P 500
EU
RNO
Renault
EU
CS
Axa
EU
ML
Michelin
EU
HO
Thales
NASDAQ
NVDA
NVIDIA
NYSE
DIS
Walt Disney
EU
AI
Air Liquide
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés